TSE:AKUAkumin Stock Price, Forecast & News

C$3.05

0.00 (0.00 %)

(As of 05/25/2020 04:00 PM ET)

Add

Compare

Today's Range

C$3.00

Now: C$3.05▼

C$3.05

50-Day Range

C$2.25

MA: C$2.90▼

C$3.21

52-Week Range

C$1.75

Now: C$3.05▼

C$5.20

Volume7,700 shs

Average Volume27,735 shs

Market CapitalizationC$213.02 million

P/E Ratio33.89

Dividend YieldN/A

BetaN/A

Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2017, the company operated 74 imaging centers located in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, arthrography, and other diagnostic or interventional radiology procedures; and medical billing services. Akumin Inc. is headquartered in Toronto, Canada.

Beat the Market (BTM) Rank^™

2.0 Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of C$5.00, Akumin has a potential upside of 63.9% from its current price of C$3.05.
Amount of Analyst Coverage
Akumin has only been the subject of 1 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
Akumin has received 20 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Akumin has received 20 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Akumin has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Akumin and other stocks. Vote “Outperform” if you believe AKU will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AKU will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Akumin does not currently pay a dividend.
Dividend Growth
Akumin does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Akumin insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Akumin is 33.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.80.
Price to Earnings Ratio vs. Sector
The P/E ratio of Akumin is 33.89, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.18.
Price to Book Value per Share Ratio
Akumin has a P/B Ratio of 1.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.90 out of 5 stars

Industry, Sector and Symbol

Stock Exchange TSE

Industry Diagnostics & Research

Sub-IndustryN/A

SectorMedical

Current SymbolTSE:AKU

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.akumin.com

Phone416-613-1391

Debt

Debt-to-Equity Ratio338.37

Current Ratio2.28

Quick Ratio2.19

Price-To-Earnings

Trailing P/E Ratio33.89

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesC$247.44 million

Price / Sales0.86

Cash FlowC$0.35 per share

Price / Cash Flow8.68

Book ValueC$1.99 per share

Price / Book1.54

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding Shares69,841,000

Market CapC$213.02 million

Next Earnings Date5/27/2020 (Estimated)

OptionableNot Optionable

Receive AKU News and Ratings via Email

Sign-up to receive the latest news and ratings for AKU and its competitors with MarketBeat's FREE daily newsletter.

Akumin (TSE:AKU) Frequently Asked Questions

How has Akumin's stock been impacted by COVID-19 (Coronavirus)?

Akumin's stock was trading at C$4.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AKU shares have decreased by 23.9% and is now trading at C$3.05. View which stocks have been most impacted by Coronavirus.

When is Akumin's next earnings date?

Akumin is scheduled to release its next quarterly earnings announcement on Wednesday, May 27th 2020. View our earnings forecast for Akumin.

How were Akumin's earnings last quarter?

Akumin Inc (TSE:AKU) announced its quarterly earnings results on Tuesday, March, 31st. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.03. The company had revenue of $101.67 million for the quarter. View Akumin's earnings history.

What price target have analysts set for AKU?

0 brokers have issued 1 year price targets for Akumin's stock. Their forecasts range from C$5.00 to C$5.00. On average, they anticipate Akumin's share price to reach C$5.00 in the next twelve months. This suggests a possible upside of 63.9% from the stock's current price. View analysts' price targets for Akumin.

Has Akumin been receiving favorable news coverage?

Press coverage about AKU stock has trended somewhat positive recently, InfoTrie reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Akumin earned a news impact score of 0.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutAkumin.

Who are some of Akumin's key competitors?

Some companies that are related to Akumin include Integral Diagnostics (IDX), Volpara Health Tech (VHT), Profound Medical (PRN), Renalytix Ai (RENX), Exagen (XGN), Yourgene Health (YGEN), Senseonics (SENS), Palatin Technologies (PTN), MaxCyte (MXCT), Oncosil Medical (OSL), Lexagene (LXG), Oncimmune (ONC), Genedrive (GDR), SQI Diagnostics (SQD) and BARD1 Life Sciences (BD1). View all competitors.

What other stocks do shareholders of Akumin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akumin investors own include Altagas (ALA), Aecon Group (ARE), Alimentation Couche-Tard (ATD.B), Brookfield Asset Management (BAM.A), Brookfield Infrastructure Partners (BIP.UN), Brookfield Property Partners (BPY.UN), CAE (CAE), Cargojet (CJT), Canadian National Railway (CNR) and Canadian Pacific Railway (CP).

Who are Akumin's key executives?

Akumin's management team includes the following people:

Mr. Riadh Zine-El-Abidine, Pres, CEO & Director (Age 47)
Mr. Mohammad Saleem, CFO & Corp. Sec.
Mr. Rohit Navani, Exec. VP & COO
Mrs. Amy Adams MBA, Sr. VP of Clinical Devel.
Ms. Laura Kassa, Sr. VP of Operations of Akumin Corp.

What is Akumin's stock symbol?

Akumin trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AKU."

How do I buy shares of Akumin?

Shares of AKU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Akumin's stock price today?

One share of AKU stock can currently be purchased for approximately C$3.05.

How big of a company is Akumin?

Akumin has a market capitalization of C$213.02 million and generates C$247.44 million in revenue each year.

What is Akumin's official website?

The official website for Akumin is www.akumin.com.

How can I contact Akumin?

The company can be reached via phone at 416-613-1391.

This page was last updated on 5/25/2020 by MarketBeat.com Staff